KFST10114-10
Danmark-København: Lægemidler
- Oplyst værdi / estimat
- 127.581.250 DKK
- Frist
- 31.8.2021
- Publiceret
- 14.6.2021
- CPV
- 33600000
- Leveringssted (NUTS)
- Ikke oplyst
- Ordregivers adresseområde (NUTS)
- DK01
Dataposten opdateret . Datakilder, dækning og beregningsmetode.
Beskrivelse
Denmark, Norway and Iceland have entered into cooperation regarding the procurement of pharmaceuticals. The countries will jointly procure and award framework agreements in order to ensure the supply of pharmaceuticals to the public hospitals and health authorities in the countries. In Denmark certain pharmaceuticals are resold to the Faroe Island and Greenland. The obligation to deliver the pharmaceuticals in Iceland is subject to the precondition that the supplier obtains an exemption regarding printed labels and leaflets. If the supplier does not obtain such exemption the agreement will only apply to Denmark and Norway, see the Framework agreement section 2.2.1 and Appendix 6.The framework agreements are non-exclusive to the supplier. The hospitals and health authorities are not obliged to use the framework agreement.
Andre bekendtgørelser i samme CPV-kategori
Nyeste bekendtgørelser med samme firecifrede CPV-kategori. Listen kan omfatte både åbne udbud og historik.
- Amgros 2026 1.630.b
Amgros I/S
- Rammeaftale om køb af Livmarli (maralixibat)
Amgros I/S
- Amgros 2027 1.1076.a
Amgros I/S
- Rammeaftale om køb af Voranigo (vorasidenib)
Amgros I/S
- Amgros 2026 1.989.a
Amgros I/S
- Amgros 2027 1.1551.a
Amgros I/S